August 5, 2024 02:01 PM EDT

Bristol Myers to cut more jobs at headquarters as part of announced restructure

Max Bayer

Pharma Reporter

Roughly two months after Bristol Myers Squibb disclosed hundreds of job cuts at its New Jersey corporate headquarters, it’s further shrinking the headcount there. …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Bristol Myers to cut more jobs at headquarters as part of announced restructure

Max Bayer

Pharma Reporter

Sign up to read this article for free.

Merck, Daiichi Sankyo detail Phase 2 ADC results in small cell lung cancer, bispecific combo strategy

Investors pour $370M+ into Ken Song's autoimmune biotech after his RayzeBio success

Summit's Phase 3 data back up biotech's boasts of beating Keytruda in lung cancer

Terns’ oral GLP-1 passes Phase 1 test with promising weight loss after one month

Relay Therapeutics reports positive PFS data for its PI3Kα inhibitor combo in breast cancer

Eli Lilly invests in Superluminal's $120M Series A round as AI-focused startups eye the clinic

Bris­tol My­ers to cut more jobs at head­quar­ters as part of an­nounced re­struc­ture

Max Bayer

Pharma Reporter

Sign up to read this article for free.

more like this

Mer­ck, Dai­ichi Sankyo de­tail Phase 2 ADC re­sults in small cell lung can­cer, bis­pe­cif­ic com­bo strat­e­gy

In­vestors pour $370M+ in­to Ken Song's au­toim­mune biotech af­ter his Rayze­Bio suc­cess

Sum­mit's Phase 3 da­ta back up biotech's boasts of beat­ing Keytru­da in lung can­cer

Terns’ oral GLP-1 pass­es Phase 1 test with promis­ing weight loss af­ter one month

Re­lay Ther­a­peu­tics re­ports pos­i­tive PFS da­ta for its PI3Kα in­hibitor com­bo in breast can­cer

Eli Lil­ly in­vests in Su­per­lu­mi­nal's $120M Se­ries A round as AI-fo­cused star­tups eye the clin­ic

Bristol Myers to cut more jobs at headquarters as part of announced restructure

Merck, Daiichi Sankyo detail Phase 2 ADC results in small cell lung cancer, bispecific combo strategy

Investors pour $370M+ into Ken Song's autoimmune biotech after his RayzeBio success

Summit's Phase 3 data back up biotech's boasts of beating Keytruda in lung cancer

Terns’ oral GLP-1 passes Phase 1 test with promising weight loss after one month

Relay Therapeutics reports positive PFS data for its PI3Kα inhibitor combo in breast cancer

Eli Lilly invests in Superluminal's $120M Series A round as AI-focused startups eye the clinic